John Bradley Sorenson - 13 Feb 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP, Global Operations
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
13 Feb 2025
Net transactions value
-$364,304
Form type
4
Filing time
18 Feb 2025, 17:52:19 UTC
Previous filing
14 Feb 2025
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +2,115 +8.3% $0.000000 27,609 14 Feb 2025 Direct F1
transaction BSX Common Stock Tax liability $102,396 -965 -3.5% $106.11 26,644 14 Feb 2025 Direct
transaction BSX Common Stock Sale $127,678 -1,201 -4.5% $106.31 25,443 14 Feb 2025 Direct F2
transaction BSX Common Stock Options Exercise $0 +1,273 +5% $0.000000 26,716 16 Feb 2025 Direct F1
transaction BSX Common Stock Tax liability $61,650 -581 -2.2% $106.11 26,135 16 Feb 2025 Direct
transaction BSX Common Stock Options Exercise $0 +1,500 +5.7% $0.000000 27,635 17 Feb 2025 Direct F1
transaction BSX Common Stock Tax liability $72,579 -684 -2.5% $106.11 26,951 17 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Award $0 +4,239 $0.000000 4,239 13 Feb 2025 Common Stock 4,239 Direct F1, F3
transaction BSX Stock Option (Right to Buy) Award $0 +10,909 $0.000000 10,909 13 Feb 2025 Common Stock 10,909 $106.14 Direct F4
transaction BSX Restricted Stock Units Options Exercise $0 -2,115 -33% $0.000000 4,230 14 Feb 2025 Common Stock 2,115 Direct F1, F5
transaction BSX Restricted Stock Units Options Exercise $0 -1,273 -50% $0.000000 1,273 16 Feb 2025 Common Stock 1,273 Direct F1, F6
transaction BSX Restricted Stock Units Options Exercise $0 -1,500 -100% $0.000000 0 17 Feb 2025 Common Stock 1,500 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F4 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F6 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F7 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.